Not Signed In - Sinovac Attended 3rd WHO Meeting On Evaluation Of Pandemic Influenza Prototype Vaccines In Clinical Trials
Wed, 21 Feb 2007 08:00 AM EST
... Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced that Sinovac attended the 3rd WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. The meeting was held on February 15 - 16, 2007 at the World Health Organization's headquarters in Geneva, Switzerland. [click link for full article] ...
Related Topics
- Influenza
- Clinical Trials
- Vaccines & Immunizations
- Influenza Vaccines
- Avian Influenza
- Pharmacology
- Psychopharmacology
- Influenza and Colds
- Clinical Growth Charts
- Combination Vaccines
- Hepatitis Vaccines
- Pediatric Aids
- Thimerosal
- Influenza Virus Vaccine
- Influenza (Flu)
- Meningococcal Vaccines
- Hepatitis A Vaccines
- Vaccines and Diabetes
- Influenza Surveillance Data
- Influenza (flu) Vaccine
email this page
print this page
bookmark this page
feedback on this page
